Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cleveland BioLabs Inc. (CBLI)

2.01   0.04 (2.03%) 10-01 15:11
Open: 1.95 Pre. Close: 1.97
High: 2.0245 Low: 1.95
Volume: 42,112 Market Cap: 26M
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees. The firm is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.021 - 2.034 2.034 - 2.046
Low: 1.885 - 1.898 1.898 - 1.908
Close: 1.951 - 1.972 1.972 - 1.99

Technical analysis

as of: 2020-10-01 2:31:47 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.78     One year: 3.25
Support: Support1: 1.91    Support2: 1.62
Resistance: Resistance1: 2.38    Resistance2: 2.78
Pivot: 2.08
Moving Average: MA(5): 2.01     MA(20): 2.03
MA(100): 2.17     MA(250): 1.73
MACD: MACD(12,26): -0.05     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 27.34     %D(3): 34.97
RSI: RSI(14): 46.19
52-week: High: 5.00  Low: 0.50  Change(%): 96.1
Average Vol(K): 3-Month: 46348  10-Days: 12695

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CBLI has closed above bottom band by 31.3%. Bollinger Bands are 57.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CBLI's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 14 Sep 2020
Cleveland BioLabs Inc. (CBLI) latest performance of 22.63% is not what was on cards - News Daemon

Fri, 11 Sep 2020
Is Cleveland BioLabs, Inc. (CBLI) Stock a Great Value? - InvestorsObserver

Mon, 24 Aug 2020
Is Cleveland BioLabs, Inc. (CBLI) Stock About to Get Hot Monday? - InvestorsObserver

Mon, 10 Aug 2020
Cleveland BioLabs Inc. (CBLI) volume hits 1.49 million: A New Opening for Investors - News Daemon

Tue, 14 Jul 2020
Is Cleveland BioLabs, Inc. (CBLI) Stock About to Get Hot Tuesday? - InvestorsObserver

Thu, 02 Jul 2020
Is Cleveland BioLabs, Inc. (CBLI) A 'Must-Own' Growth Stock? - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 13
Shares Float (M) 6
% Held by Insiders 64.39
% Held by Institutions 3.68
Shares Short (K) 143
Shares Short P. Month (K) 198

Stock Financials

EPS -0.184
EPS Est This Year -0.160
EPS Est Next Year -0.480
Book Value (p.s.) -0.130
Profit Margin -246.62
Operating Margin -213.98
Return on Assets (ttm) -32.0
Return on Equity (ttm) -79.0
Qtrly Rev. Growth -77.2
Gross Profit (p.s.) -0.042
Sales Per Share 0.066
EBITDA (p.s.) -0.141
Qtrly Earnings Growth
Operating Cash Flow (M) -2
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -10.87
PEG Ratio
Price to Book value -15.38
Price to Sales 30.12
Price to Cash Flow -13.05

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.